FDA Approves Xenpozyme for ASMD, a Rare Genetic Disorder

Press/Media

Period	1 Sep 2022

Media coverage

Title	FDA Approves Xenpozyme for ASMD, a Rare Genetic Disorder
Media name/outlet	Formulary Watch
Country/Territory	United States
Date	1/09/22
URL	https://www.formularywatch.com/view/fda-approves-xenpozyme-for-asmd-a-rare-genetic-disorder
Persons	Melissa Wasserstein